Skip to main content

Advertisement

Log in

Activity of Antioxidant Enzymes and Content of Reduced Glutathione in Cells of Drug-Resistant Murine Leukemia P388 Strains

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Activities of superoxide dismutase and catalase and content of reduced glutathione in cells of drug-resistant murine leukemia P388 strains were studied without or after administration of antitumor compounds. In the absence of chemotherapeutic agents, no significant differences in activities of the studied enzymes in cells of the initial strain and strains resistant to cyclophosphamide, cisplatin, and rubomycin were observed. Compounds to which resistance was developed did not significantly affect activity of enzymes in cells of drug-resistant strains, while the use of compounds that were not resistance inductors was accompanied by a significant decrease in enzyme activity in cells resistant to cisplatin and rubomycin. In cells of strains resistant to cisplatin and cyclophosphamide, the content of reduced glutathione significantly differed from that in the initial strain. In addition, the concentration of reduced glutathione in cells of cyclophosphamide-resistant strain considerably decreased upon addition of the drug producing a therapeutic effect. Our findings suggest that the mechanism of resistance of in vivo derived cyclophosphamide resistant cell strain is related to increased level of reduced glutathione and activity of its metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Goncharova SA, Raevskaya TA, Yakushchenko TN, Blokhina SV, Konovalova NP, Sen’ VD. Synergistic antitumor effect of cisplatin and the platinum(IV) nitroxyl complex BC118 and the development of resistance to their combined action. Russ. Chem. Bull. 2011;60(9):1944-1947.

    Article  CAS  Google Scholar 

  2. Manual for Preclinical Studies of New Pharmacological Substances. Mironov AN, ed. Moscow, 2012. Russian.

  3. Mumyatova VA, Balakina AA, Filatova NV, Sen’ VD, Korepin AG, Terentev AA. Effect of Cytotoxic Compounds on Activity of Antioxidant Enzyme System in MCF-7 and H1299 Cells. Bull. Exp. Biol. Med. 2016;161(1):179-183.

    Article  CAS  PubMed  Google Scholar 

  4. Treshchalina EM, Zhukova OS, Gerasimova GK, Andronova NV, Garin AM. Methodological Guidelines for Study of Antitumor Activity of Pharmacological Agents. Manual on Experimental (Preclinical) Study of New Pharmacological Substances, Khabriev RU, ed. Moscow, 2005. P. 637-651. Russian.

  5. Byun SS, Kim S. W, Choi H, Lee C, Lee E. Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities. BJU Int. 2005;95(7):1086-1090.

    Article  CAS  PubMed  Google Scholar 

  6. Cook JA, Gius D, Wink DA, Krishna MC, Russo A, Mitchell JB. Oxidative stress, redox, and the tumor microenvironment. Semin. Radiat. Oncol. 2004;14(3):259-266.

    Article  PubMed  Google Scholar 

  7. Furusawa S, Kimura E, Kisara S, Nakano S, Murata R, Tanaka Y, Sakaguchi S, Takayanagi M, Takayanagi Y, Sasaki K. Mechanism of resistance to oxidative stress in doxorubicin resistant cells. Biol. Pharm. Bull. 2001;24(5):474-479.

    Article  CAS  PubMed  Google Scholar 

  8. Gibellini L, Pinti M, Nasi M, De Biasi S, Roat E, Bertoncelli L, Cossarizza A. Interfering with ROS metabolism in cancer cells: the potential role of quercetin. Cancers. 2010;2(2):1288-1311.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Lien EC, Lyssiotis CA, Juvekar A, Hu H, Asara JM, Cantley LC, Toker A. Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer. Nat. Cell Biol. 2016;18(5):572-578.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Mehta K, Fok J, Miller FR, Koul D, Sahin AA. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer. Clin. Cancer Res. 2004;10(23):8068-8076.

    Article  CAS  PubMed  Google Scholar 

  11. Tsuruo T, Naito M, Tomida A, Fujita N, Mashima T, Sakamoto H, Haga N. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci. 2003;94(1):15-21.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. A. Balakina.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 167, No. 3, pp. 310-314, March, 2019

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Balakina, A.A., Raevskaya, T.A., Pavlov, V.S. et al. Activity of Antioxidant Enzymes and Content of Reduced Glutathione in Cells of Drug-Resistant Murine Leukemia P388 Strains. Bull Exp Biol Med 167, 339–342 (2019). https://doi.org/10.1007/s10517-019-04522-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-019-04522-z

Key Words

Navigation